India to Kenya: Clarithromycin Export Trade Route
India has recorded 137 verified shipments of Clarithromycin exported to Kenya, representing a combined trade value of $5.8M USD. This corridor is served by 37 active Indian exporters, with an average shipment value of $42.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 60% of total export value with 11 shipments worth $3.5M USD. On the buying side, CIPLA KENYA LTD C/O IMPERIAL MANAGE is the largest importer in Kenya with $3.2M USD in purchases. The top 3 suppliers — CIPLA LIMITED, MICRO LABS LIMITED, FREDUN PHARMACEUTICALS LTD — together control 77% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Clarithromycin corridor is one of India's established pharmaceutical export routes, with 137 shipments documented worth a combined $5.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's clarithromycin manufacturing sector.
Across 37 active suppliers, the average shipment value stands at $42.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 24.5%, placing it at rank #6 among India's top clarithromycin export destinations globally.
On the import side, key buyers of Indian clarithromycin in Kenya include CIPLA KENYA LTD C/O IMPERIAL MANAGE, M/S LABOREX KENYA LIMITED, M S LABOREX KENYA LIMITED and 45 others. CIPLA KENYA LTD C/O IMPERIAL MANAGE is the single largest importer with 2 shipments valued at $3.2M USD.
